Compare Emgality vs. Frova

Emgality (galcanezumab) and Frova (frovatriptan) are both used to manage migraines, but they work differently and are used in different ways. Emgality is a monoclonal antibody that prevents migraines and treats cluster headaches by blocking a protein called calcitonin-gene related peptide (CGRP). It's given as a monthly injection under the skin. On the other hand, Frova is a triptan that treats migraines by tightening blood vessels in the brain and stopping pain-causing chemicals. It's taken as a pill when you feel a migraine coming on and can be taken again after two hours if needed. Emgality is not available in a generic form, while Frova is available as a lower-cost generic. Emgality is used for prevention, while Frova is for short-term treatment. Emgality's common side effects include injection site reactions, while Frova can cause dizziness and tiredness.